COVID-19 in Patients With Chronic Liver Diseases (COLD)

Stanford University

Status: Completed

Conditions: COVID-19; Chronic Liver Disease

Treatments: Other: Prospective Chart Review

Study type: Observational

Funder types: Other

Identifiers

NCT04439084

55819

Details and patient eligibility

About

This study seeks to determine how COVID-19 affects the clinical outcome of patients with chronic liver disease, and whether the clinical course of COVID-19 is influenced by underlying chronic liver disease.

Enrollment: 1,025 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Confirmed diagnosis of COVID-19

• Personal history of either

  • Chronic hepatitis C
  • Chronic hepatitis B
  • Alcoholic liver disease
  • Non alcoholic liver disease
  • Autoimmune hepatitis, Primary biliary cholangitis, Primary sclerosing cholangitis
  • Cryptogenic cirrhosis
  • Hepatocellular carcinoma

Exclusion criteria

• Non-COVID-19 patient

Trial design

1,025 participants in 2 patient groups

Chronic Liver Disease Group

Description:

COVID-19 patients with Chronic Liver Disease.

Treatment:

Other: Prospective Chart Review

Control Group

Description:

COVID-19 patients without Chronic Liver Disease.

Treatment:

Other: Prospective Chart Review